Biomedical Ethics in Performing Arts Medicine Research

2007 ◽  
Vol 22 (3) ◽  
pp. 87-88
Author(s):  
Ralph A Manchester
Keyword(s):  
Health Care Professionals ◽  
Performing Arts ◽  
Human Subjects ◽  
Biomedical Ethics ◽  
Major Influence ◽  
Performing Arts Medicine ◽  
Quarter Century ◽  
Medicine Research ◽  
Medical Centers ◽  
Academic Medical

As the field of performing arts medicine continues to advance, it is essential that we maintain the trust that has been built over the last quarter century with the dancers, musicians, and other performing artists we serve. Trust is a precious commodity that is built over time, largely between individual health care professionals and the patients for whom they care. However, other things we do (or don't do) can have a major influence on the trust and confidence that others place in us. One of these is research and the way we conduct research, especially when it involves human subjects. The public's confidence in medical researchers has been shaken in the last few years as the result of a few well-publicized “bad outcomes” in clinical studies being done at leading academic medical centers in the U.S. and elsewhere. While we are unlikely to do gene-transfer or new drug development studies in an effort to address the health problems of musicians and dancers, we should still hold ourselves to the same ethical standards that apply to the rest of the healthcare world.

CTSA Institution Responses to Proposed Common Rule Changes: Did They Get What They Wanted?

2017 ◽  
Vol 12 (2) ◽  
pp. 79-86 ◽  
Author(s):  
Suzanne M. Rivera ◽  
Lisa Nichols ◽  
Lois Brako ◽  
Genevieve Croft ◽  
Toni Russo ◽  
...  
Keyword(s):  
Human Services ◽  
Human Subjects ◽  
National Institutes Of Health ◽  
Academic Medical Centers ◽  
Department Of Health ◽  
Medical Centers ◽  
Academic Medical ◽  
Rule Changes ◽  
Final Rule ◽  
Protection Of Human Subjects

In 2015, the U.S. Department of Health and Human Services (HHS) and 15 other federal departments and agencies proposed revisions to the Federal Policy for the Protection of Human Subjects. In this Notice of Proposed Rulemaking (NPRM), the departments sought to strengthen, modernize, and make more effective human subjects regulations while reducing administrative burden, delay, and ambiguity. We reviewed public comments from National Institutes of Health (NIH)-funded Clinical and Translational Science Awards (CTSA) institutions on key provisions of the NPRM to understand how the proposed changed were received at research-intensive institutions. CTSA institutions responding to the proposed rule were predominantly opposed to the major proposals, including proposed changes to the treatment of de-identified biospecimens, demonstrating a lack of support from academic medical centers. In January 2017, a Final Rule was issued. We compare the Final Rule to what was proposed.

The Digital Era of Performing Arts Medicine Research

2019 ◽  
Vol 34 (4) ◽  
pp. 230-231
Author(s):  
Bronwen J Ackermann
Keyword(s):  
Performance Analysis ◽  
Performing Arts ◽  
Print Media ◽  
Modern Technology ◽  
Performing Arts Medicine ◽  
New Era ◽  
Medicine Research ◽  
Online System ◽  
Digital Era ◽  
The Way

As MPPA moves into the next decade, the challenges faced by maintaining print media in an increasingly paperless society has led to the journal being published online only from March 2020 onwards. While it is a little sad to farewell the colourful covers and textures of the paper journal, there will be advantages in accessibility and immediacy of publishing with the new online system, and we look forward to the new era. Indeed, modern technology has changed the way we analyse a multitude of variables in research, and we see in this issue several examples of performance analysis using highly sophisticated devices.

Readability Level of Health Insurance Portability and Accountability Act Notices of Privacy Practices Utilized by Academic Medical Centers

2005 ◽  
Vol 28 (4) ◽  
pp. 479-486 ◽  
Author(s):  
Steven Walfish ◽  
Keely M. Watkins
Keyword(s):  
Health Insurance ◽  
Health Care Professionals ◽  
Medical Center ◽  
Academic Medical Center ◽  
Reading Level ◽  
Academic Medical Centers ◽  
Medical Centers ◽  
Academic Medical ◽  
Assessment And Treatment ◽  
Health Insurance Portability

Recently enacted Health Insurance Portability and Accountability Act legislation requires health care professionals to provide patients with a “Notice of Privacy Practices” (NPP) document as part of their informed consent process to participate in assessment and treatment. We were interested in the readability of these forms. We attempted to find a NPP from an academic medical center in each state plus the District of Columbia where documents were placed on the institution's Web site. Documents were obtained from 40 jurisdictions and were then analyzed utilizing two measures of readability. The majority (65%) of these documents were written beyond the 12thgrade reading level, and almost the entire sample (90%) fell in the difficult range of reading ease. Academic medical centers have an ethical obligation to improve the readability of these documents and should do so to improve clinical practice and reduce liability.

Oefening Baart Kunst—“Exercise Bears (Gives Birth To) Art”: Symposium for and by the Allied Health Professions of the NVDMG, Medisch Centrum Haaglanden, Den Haag, February 5, 2011

2011 ◽  
Vol 26 (2) ◽  
pp. 108-113
Author(s):  
ABM Rietveld ◽  
John D Macfarlane
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Health Care Professionals ◽  
Performing Arts ◽  
Allied Health ◽  
Care Providers ◽  
Performing Arts Medicine ◽  
Allied Health Care ◽  
Related Approach ◽  
Nederlandse Vereniging Voor

On Saturday, February 5th, 2011, the Dutch Performing Arts Medicine Association (Nederlandse Vereniging voor Dans- en MuziekGeneeskunde, NVDMG) organized a Symposium for and by allied health care professionals, held in the Medisch Centrum Haaglanden (MCH, Medical Centre of The Hague). Allied health care professionals, such as physiotherapists, manual therapists, Mensendieck therapists, speech therapists, and foot therapists, form a vital and indispensable link in the chain of healthcare and cure for dancers, musicians, and singers. The intention of the symposium was to highlight the practical and experience-related approach of allied health care providers, both in the presentations and in the artistic intermezzi. Apart from the exchange of knowledge and experience, there was ample opportunity for informal contact, facilitating and stimulating the formation of an interdependent network of allied health care providers specialized and/or interested in dance, music, and singing in The Netherlands.

Economic Uncertainty and Performing Arts Medicine

2012 ◽  
Vol 27 (4) ◽  
pp. 173-174
Author(s):  
Ralph A Manchester
Keyword(s):  
Health Care ◽  
Chest Pain ◽  
Myocardial Ischemia ◽  
Health Care Professionals ◽  
Performing Arts ◽  
Economic Uncertainty ◽  
Performing Arts Medicine ◽  
Performing Artists ◽  
Arm Pain ◽  
Economic Trends

Performing artists are used to dealing with uncertainty-—how will the next performance go, what will the new conductor expect, will my current combination of jobs and gigs be enough to pay the bills? Likewise, health care professionals have to deal with uncertainty on a regular basis—-is the patient’s chest pain due to myocardial ischemia or something else, will the treatment I prescribed for the pianist with arm pain be effective? But all of us on every continent are dealing with a great deal of economic uncertainty these days. ... How will these economic trends affect performing artists and the health care professionals who provide care for them?

scholarly journals Are Changes to the Common Rule Necessary to Address Evolving Areas of Research?

2013 ◽  
Vol 41 (2) ◽  
pp. 454-469 ◽  
Author(s):  
Diane E. Hoffmann ◽  
J. Dennis Fortenberry ◽  
Jacques Ravel
Keyword(s):  
Human Subjects ◽  
Computer Software ◽  
The United States ◽  
Common Rule ◽  
Department Of Health ◽  
Medical Centers ◽  
Technological Advances ◽  
Academic Medical ◽  
The Common ◽  
New Research

The proposed changes to the Common Rule, described in the recent Advanced Notice of Proposed Rulemaking (ANPRM), come more than 20 years after the U.S. Department of Health and Human Services adopted the Rule in 1991. Since that time, human subjects research has changed in significant ways. Not only has the volume of clinical research grown dramatically, this research is now regularly conducted at multiple collaborative sites that are often outside of the United States. Research takes place not only in academic medical centers, but also at outpatient clinics, community hospitals, and other nontraditional venues. In addition, technological advances, such as sophisticated computer software programs, the Internet, social media, new research methods, and mobile applications have exponentially increased the volume of data available and the possibilities for accessing, analyzing, and sharing that data.

Technology in Performing Arts Healthcare Research

2014 ◽  
Vol 29 (3) ◽  
pp. 121-122
Author(s):  
Ralph A Manchester
Keyword(s):  
Performing Arts ◽  
Magnetic Stimulation ◽  
Corticospinal Tract ◽  
State Of The Art ◽  
Three Dimensional ◽  
Healthcare Research ◽  
Medical Problems ◽  
Performing Arts Medicine ◽  
Medicine Research ◽  
Use Of Technology

Two articles in this issue of Medical Problems of Performing Artists use specific technologies to advance our understanding of particular aspects of performance health. Clemente et al. used three-dimensional accelerometers to measure the motion of the head, jaw, and neck in pianists. Saito et al. used electromyography (EMG) in the soleus muscles of dancers along with transcranial magnetic stimulation to show that the corticospinal tract adapts to the demands of dancing. These two examples of the use of technology in performing arts medicine research led me to review past issues of the journal to get a better sense of which technologies have been more or less frequently used and how they have contributed to the state of the art.

scholarly journals Multicenter point prevalence evaluation of the utilization and safety of drug therapies for COVID-19 at the onset of the pandemic timeline in the United States

2021 ◽  
Author(s):  
Nathaniel J Rhodes ◽  
Atheer Dairem ◽  
William J Moore ◽  
Anooj Shah ◽  
Michael J Postelnick ◽  
...  
Keyword(s):  
Clinical Trials ◽  
Drug Therapy ◽  
Supportive Care ◽  
The United States ◽  
Primary Objective ◽  
Point Prevalence ◽  
Medical Centers ◽  
Academic Medical ◽  
History Of ◽  
Secondary Objective

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose There are currently no FDA-approved medications for the treatment of coronavirus disease 2019 (COVID-19). At the onset of the pandemic, off-label medication use was supported by limited or no clinical data. We sought to characterize experimental COVID-19 therapies and identify safety signals during this period. Methods We conducted a non-interventional, multicenter, point prevalence study of patients hospitalized with suspected/confirmed COVID-19. Clinical and treatment characteristics within a 24-hour window were evaluated in a random sample of up to 30 patients per site. The primary objective was to describe COVID-19–targeted therapies. The secondary objective was to describe adverse drug reactions (ADRs). Results A total of 352 patients treated for COVID-19 at 15 US hospitals From April 18 to May 8, 2020, were included in the study. Most patients were treated at academic medical centers (53.4%) or community hospitals (42.6%). Sixty-seven patients (19%) were receiving drug therapy in addition to supportive care. Drug therapies used included hydroxychloroquine (69%), remdesivir (10%), and interleukin-6 antagonists (9%). Five patients (7.5%) were receiving combination therapy. The rate of use of COVID-19–directed drug therapy was higher in patients with vs patients without a history of asthma (14.9% vs 7%, P = 0.037) and in patients enrolled in clinical trials (26.9% vs 3.2%, P < 0.001). Among those receiving drug therapy, 8 patients (12%) experienced an ADR, and ADRs were recognized at a higher rate in patients enrolled in clinical trials (62.5% vs 22%; odds ratio, 5.9; P = 0.028). Conclusion While we observed high rates of supportive care for patients with COVID-19, we also found that ADRs were common among patients receiving drug therapy, including those enrolled in clinical trials. Comprehensive systems are needed to identify and mitigate ADRs associated with experimental COVID-19 treatments.

Sign in / Sign up

Export Citation Format

Share Document